Cells use mRNA to build proteins, and after years of research, scientists learned how to harness this molecule to develop effective, safe and quick-to-make vaccines. Since the advent of this Nobel ...

A slightly disappointing revenue outlook from Pfizer (PFE) was enough for its COVID-19 vaccine rivals Moderna (MRNA) and Novavax (NVAX) to trade lower on Tuesday, just as a major safety scare related ...

Throughout 2025, CancerVax achieved substantial scientific progress, expanded its leadership and intellectual property portfolio, and advanced the development of its AI-engineered "Smart mRNA" and ...

A new cozy, historically inspired city-building game Zlín City: Arch Moderna has been announced, bringing a sense of realism ...

The COVID vaccines have saved millions of lives from a virus that has killed more than seven million people globally. Many safety studies and real-world evidence from billions of doses show that the ...

In addition to its Chinese R&D and manufacturing centers in Beijing and Suzhou, Ribo also set up a subsidiary, Ribocure AB, ...

DECADES of virology research that yielded the human papillomavirus (HPV) vaccine and identified the virus as a primary cause ...

Following a feud with activist investor Deep Track Capital in the first half of 2025, vaccine developer Dynavax Technologies ...

The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...

The French pharma major has started a $15.50 per share cash tender offer for Emeryville, California-based Dynavax, which ...

"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...